GoAI
Get started
Recovery International Co.,Ltd. logo

Recovery International Co.,Ltd.

9214.T

JPXHealthcareMedical - Care Facilities

Open in GoAI

Latest quote

¥1,304

+¥20.00 · +1.56%

Aug 24, 12:30 PM JSTData delayed

9214.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Based in Shinjuku-Ku, Japan, and incorporated in 2013, Recovery International Co.,Ltd. delivers a range of in-home care and rehabilitation services throughout Japan. The company offers domiciliary nursing support to individuals grappling with illness or disability. Furthermore, it deploys physical therapists, occupational therapists, and speech-language pathologists to assist clients in preserving and enhancing their cognitive and physical capabilities. Patients with physical handicaps can also benefit from the company's home-visit massage services.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
JP
CEO
Junya Shibata
Listed since
Feb 3, 2022
Employees
280

Market position

Day range

Current ¥1,304

52-week range

Current ¥1,304

Open
¥1,312
Previous close
¥1,284
Volume
300
0.29× average
Average volume
1.03K
Average daily volume
Market cap
1.7B JPY
Beta
0.45
Market reference 1
50-day average
¥1,266.74
+2.94% above average
200-day average
¥1,365.5
-4.50% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.56B JPY
P/E (TTM)
15.86×
P/B (TTM)
2.26×
P/S (TTM)
0.57×
EV / EBITDA
7.25×
Earnings yield
6.49%
Free cash flow yield
3.33%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
42.31%
Operating margin
5.87%
Net margin
3.71%
Return on equity
16.49%
Return on assets
9.47%
Return on invested capital
12.71%

Financial health

Debt / equity
0.21×
Current ratio
2.96×
Altman Z-score
5.76
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends47%31%16%1%Gross margin, FY2021: 40.23%Gross margin, FY2022: 38.75%Gross margin, FY2023: 39.89%Gross margin, FY2024: 41.88%Gross margin, FY2025: 42.94%Operating margin, FY2021: 12.99%Operating margin, FY2022: 11.18%Operating margin, FY2023: 9.38%Operating margin, FY2024: 8.86%Operating margin, FY2025: 7.56%Net margin, FY2021: 8.98%Net margin, FY2022: 7.82%Net margin, FY2023: 6.86%Net margin, FY2024: 7.13%Net margin, FY2025: 4.75%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 40.23%. Gross margin FY2022 38.75%. Gross margin FY2023 39.89%. Gross margin FY2024 41.88%. Gross margin FY2025 42.94%. Operating margin FY2021 12.99%. Operating margin FY2022 11.18%. Operating margin FY2023 9.38%. Operating margin FY2024 8.86%. Operating margin FY2025 7.56%. Net margin FY2021 8.98%. Net margin FY2022 7.82%. Net margin FY2023 6.86%. Net margin FY2024 7.13%. Net margin FY2025 4.75%.

Income trends

Revenue

2.69B JPY+31.64%

Operating income

203.39M JPY+12.37%

Net income

127.71M JPY-12.37%
Income trends across reported periods2.95B JPY1.91B JPY877.49M JPY−158.01M JPYRevenue, FY2021: 1.12B JPYRevenue, FY2022: 1.39B JPYRevenue, FY2023: 1.61B JPYRevenue, FY2024: 2.04B JPYRevenue, FY2025: 2.69B JPYOperating income, FY2021: 145.82M JPYOperating income, FY2022: 154.86M JPYOperating income, FY2023: 150.49M JPYOperating income, FY2024: 181M JPYOperating income, FY2025: 203.39M JPYNet income, FY2021: 100.86M JPYNet income, FY2022: 108.3M JPYNet income, FY2023: 110.14M JPYNet income, FY2024: 145.73M JPYNet income, FY2025: 127.71M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.12B JPY. Revenue FY2022 1.39B JPY. Revenue FY2023 1.61B JPY. Revenue FY2024 2.04B JPY. Revenue FY2025 2.69B JPY. Operating income FY2021 145.82M JPY. Operating income FY2022 154.86M JPY. Operating income FY2023 150.49M JPY. Operating income FY2024 181M JPY. Operating income FY2025 203.39M JPY. Net income FY2021 100.86M JPY. Net income FY2022 108.3M JPY. Net income FY2023 110.14M JPY. Net income FY2024 145.73M JPY. Net income FY2025 127.71M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue2.69B JPY2.04B JPY1.61B JPY1.39B JPY1.12B JPY
Cost of goods sold1.53B JPY1.19B JPY964.8M JPY848.6M JPY671.06M JPY
Gross profit1.15B JPY855.68M JPY640.22M JPY536.81M JPY451.77M JPY
Selling, general, and administrative951.52M JPY674.68M JPY489.73M JPY381.95M JPY305.95M JPY
Operating expenses951.52M JPY674.68M JPY489.73M JPY381.95M JPY305.95M JPY
Interest income859K JPY————
Interest expense1.91M JPY96K JPY376K JPY762K JPY1.17M JPY
Depreciation and amortization11.78M JPY5.17M JPY7.12M JPY9.85M JPY4.3M JPY
Operating income203.39M JPY181M JPY150.49M JPY154.86M JPY145.82M JPY
Net income127.71M JPY145.73M JPY110.14M JPY108.3M JPY100.86M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
13.7

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates62.3237.0511.79-13.48Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 35.36, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 47.04, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 30.48, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 13, 2025: actual -8.25, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 12, 2025: actual 13.87, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 16, 2026: actual 57.09, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual -2.51, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 12, 2026: actual 13.7, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates841.36M729.79M618.21M506.64MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual 539M JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 12, 2025: actual 575M JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 572.32M JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 13, 2025: actual 654.92M JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 12, 2025: actual 697M JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 16, 2026: actual 765M JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 738M JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 12, 2026: actual 809M JPY, estimate —, surprise —, Comparison unavailable.

9214.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,009

-0.03%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,814

+0.87%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,000

+0.42%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,285

+0.74%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,396.5

+0.40%

Continue in GoAI

Research 9214.T

research.disclaimer